step 9: completion of clinical trial and ending an ind | regulatory learnings | dra
Published 2 years ago • 897 plays • Length 5:32Download video MP4
Download video MP3
Similar videos
-
5:30
what is investigational new drug (ind) application? | regulatory learnings | drug regulatory affairs
-
4:42
step 7: how are clinical trials registered in usa? | regulatory learnings
-
4:25
step-wise approach for investigational new drug (ind) application? | regulatory learnings | dra
-
4:15
step 8: how to do ind life cycle management? | regulatory learnings| dra
-
6:43
step 4: types of usfda forms for ind application (part 2)? | regulatory learnings | dra
-
10:26
what is clinical trial? | regulatory learnings | drug regulatory affairs
-
10:33
what are the steps and timelines for decentralised procedure and mutual recognition procedure?| dra
-
10:53
cdsco releases draft guidelines for clinical trials in india
-
57:45
inside the fda: a clinician's guide to the drug approval process
-
1:04:20
master class - fda pre-submissions
-
8:17
step 4: what content do we include in ind application (part 1)? | regulatory learnings | dra
-
3:54
the four phases of clinical trials | diversity in clinical trials | akf
-
3:13
step 6: how does usfda review an investigational new drug (ind) application (part 2)? | dra
-
8:11
regulatory shorts#1 | covid-19 vaccine | expanded access vs emergency use authorization vs off-label
-
16:57
eu marketing authorisation | what are the steps and timelines for centralised procedure at ema?| dra
-
7:54
step 3: what are the types of usfda meetings (part 2)? | regulatory learnings | dra
-
0:13
clinical research: phase 3 clinical trials
-
3:25
how to register an investigational new drug (ind) to the us fda
-
21:48
ep 9: the fda and irb: how they work & what you need to know
-
41:00
fda regulatory requirements for clinical investigators and case examples (9of14) redi 2018
-
1:03:49
webinar - discovering the many advantages of conducting early phase clinical trials in na